NCT00203775|Terminated
Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates
Efficacy of Risperidone Versus Haloperidol in the Treatment of Aggression and Hostility in Psychotic Inmates
Loading search results
Efficacy of Risperidone Versus Haloperidol in the Treatment of Aggression and Hostility in Psychotic Inmates
Sponsor study identifier
Secondary identifiers
interventional
N/A
1 country
1
Study Start
July 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates. It is hypothsized that risperdal will be more effective in decreasing aggression than haldol.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2002
Date type not reportedThis date has not been verified as actual or estimated.
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
September 12, 2005
Actual (reported)September 20, 2005
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
University of connecticut health center
Farmington, Connecticut, 06030, United States
catherine f lewis, md
UConn Health
First Submitted
September 12, 2005
First Posted
September 20, 2005
Study Start
July 2002
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
April 2004
Date type not reportedBioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions
This date has not been verified as actual or estimated.
Last Updated
October 13, 2006
Record last verified: 2005-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: